EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis

Chenyang Han iD, Jian Sheng, Hongyan Pei, Wenyan Li, Shasha Wu, Yi Yang iD, Chenxi Cao iD, Zhiling Tang iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70424 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Chenyang Han and 7 co-authors. Institution: Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China. Major MEDLINE topics: Ferroptosis, Deoxyadenosines, Non-alcoholic Fatty Liver Disease. 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Jiaxing Science and technology planning project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

To investigate the effects and targets of cordycepin (COR) in alleviating non‐alcoholic fatty liver disease (NAFLD). High‐fat diet was used to induce NAFLD in mice, and after COR gavage administration, changes in liver function, glucose and lipid metabolism, and ferroptosis‐related signaling were detected. In vitro, palmitic acid (PA) and oleic acid (PSA) were combined to induce hepatocyte lipid injury. The effect of COR on hepatocyte ferroptosis was examined. GCH1 conditional knockout mice (GCH1‐CKO) and hepatocyte models were constructed, and AAV9‐GCH1 was used to construct GCH1 overexpression mouse models to verify the effect of GCH1 on NAFLD. CETSA‐WB, co‐immunoprecipitation, and DARTS were employed in the COR‐GCH1 interaction and mechanism studies to validate the targeted binding relationship between COR and GCH1. Animal‐level studies showed that COR could improve glucose and lipid metabolism and liver function damage in mouse NAFLD, inhibit ferroptosis occurrence and lipid peroxidation injury. Cell‐level results showed that COR could inhibit hepatocyte ferroptosis. The ferroptosis‐inhibiting effect of GCH1 is independent of GPX4 and other signals; GCH1 directly inhibits reactive oxygen free radicals and suppresses lipid metabolism peroxidation damage. COR's effects are not related to classical anti‐ferroptosis signals such as GPX4 and Nrf2, but only related to GCH1. COR can target the GCH1 K155 site, stabilize protein levels by inhibiting GCH1 ubiquitination degradation, and when GCH1 is knocked out, COR's effects are antagonized. GCH1 has a protective role in NAFLD, and this effect is independent of classical GPX4 signaling. COR can target the GCH1 K155 site, inhibit GCH1 ubiquitination thereby preventing protein degradation and exerting protein stabilization. COR elevates GCH1 levels to inhibit ferroptosis. COR is a small molecule with potential for treating NAFLD.

Subjects

MeSH terms (MEDLINE)

FerroptosisDeoxyadenosinesNon-alcoholic Fatty Liver DiseaseAnimalsMiceHepatocytesMice, KnockoutMaleLipid MetabolismMice, Inbred C57BLLipid PeroxidationDiet, High-FatHumansLiverDisease ProgressionSignal Transduction

Author keywords

GCH1cordycepinferroptosisnon‐alcoholic fatty liver diseaseubiquitination

Substances

Deoxyadenosinescordycepin

Authors and institutions

  • Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
  • Department of Urology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
  • College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, Jilin, China.
  • Department of Oncology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.

ORCID profiles: Chenyang Han, Yi Yang, Chenxi Cao, Zhiling Tang

Funding

  • Jiaxing Science and technology planning project

Cite

APA

Han, C., Sheng, J., Pei, H., Li, W., Wu, S., Yang, Y., Cao, C., & Tang, Z. (2026). Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis. Phytotherapy Research. https://doi.org/10.1002/ptr.70424

Vancouver

Han C, Sheng J, Pei H, Li W, Wu S, Yang Y, et al. Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis. Phytotherapy Research. 2026. doi:10.1002/ptr.70424

BibTeX
@article{Han2026,
  author = {Han, Chenyang and Sheng, Jian and Pei, Hongyan and Li, Wenyan and Wu, Shasha and Yang, Yi and Cao, Chenxi and Tang, Zhiling},
  title = {Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70424}
}
Start for free →